MC 364 Arachidonic acid, [1-14C]- Click here for Typical Certificate of Analysis |
|
CH3(CH2)4(CH=CHCH2)4(CH2)2COOH | |
|
|
Ethanol solution under argon, 50 µCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
> 50 mCi(1.85 GBq)/mmol | 10 µCi (370 kBq) $1240 |
NextGen V-Vial - shipped on dry ice | 50 µCi (1.85 MBq) $3970 |
M.W. 304.47 | 250 µCi (9.25 MBq) $6170 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 364AT Arachidonic acid, [1-14C]- |
|
CH3(CH2)4(CH=CHCH2)4(CH2)2COOH | |
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
Toluene solution containing 0.005M ethoxyquin, 20 µCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
> 50 mCi(1.85 GBq)/mmol | 10 µCi (370 kBq) $1240 |
Sealed ampoule - shipped on dry ice | 50 µCi (1.85 MBq) $3970 |
M.W. 304.47 |
250 µCi (9.25 MBq) $6170 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 364T Arachidonic acid, [1-14C]- |
|
CH3(CH2)4(CH=CHCH2)4(CH2)2COOH | |
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
Toluene solution (without antioxidants) under argon, 20 µCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
> 50 mCi(1.85 GBq)/mmol | 10 µCi (370 kBq) $1240 |
Sealed ampoule - shipped on dry ice | 50 µCi (1.85 MBq) $3970 |
M.W. 304.47 |
250 µCi (9.25 MBq) $6170 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 901 Arachidonic acid, [5,6,8,9,11,12,14,15-3H(N)]- Click here for Typical Certificate of Analysis |
|
CH3(CH2)4(CHHCH2)4(CH2)2COOH | |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
Ethanol solution under argon, 1 mCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
> 180 Ci(6.66 TBq)/mmol | |
NextGen V-Vial - shipped on dry ice | Please Inquire for Pricing |
M.W. 304.47 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 901L Arachidonic acid, [5,6,8,9,11,12,14,15-3H(N)]- |
|
CH3(CH2)4(CHHCH2)4(CH2)2COOH | |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
Ethanol solution under argon, 1 mCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
60-180 Ci(2.22-6.66 TBq)/mmol | |
NextGen V-Vial - shipped on dry ice | Please Inquire for Pricing |
M.W. 304.47 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 901T Arachidonic acid, [5,6,8,9,11,12,14,15-3H(N)]- |
|
Click here for Typical Certificate of Analysis | |
CH3(CH2)4(CHHCH2)4(CH2)2COOH | |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
Toluene solution under argon, 1 mCi/ml - This material requires a strong PVC overpack for shipment. See details. | |
180-240 Ci(6.66-8.88 TBq)/mmol | |
Sealed ampoule - shipped on dry ice | Please Inquire for Pricing |
M.W. 304.47 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |